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Carbapenem-resistant Pseudomonas aeruginosa is a critical threat to public health ([@B1]). P. aeruginosa K34-7 belongs to sequence type 233 (ST233) and is an extensively drug-resistant (XDR), carbapenem-resistant clinical isolate expressing the Verona integron-encoded metallo-β-lactamase (VIM-2) ([@B2]). ST233 has been identified as a high-risk clone in both Mexico ([@B3]) and the United States ([@B4]). K34-7 was the first metallo-β-lactamase-producing P. aeruginosa isolate identified in Norway, and PCR analysis previously confirmed that the *bla*~VIM-2~ gene was contained within an unusual class 1 integron (GenBank accession number [FM165436](https://www.ncbi.nlm.nih.gov/nuccore/FM165436)) ([@B2]). As only one other P. aeruginosa ST233 complete genome has been published ([@B5]), this high-quality P. aeruginosa K34-7 genome will provide a valuable additional genomic resource for investigation of this high-risk ST.

Genomic DNA was prepared from a culture grown from a single colony using the Mo Bio DNeasy UltraClean microbial kit (Qiagen, USA) and sequenced on a PacBio RS II platform. A standard library of 20-kb fragments was prepared using the BluePippin preparative electrophoresis system (Sage Science, USA) with a 9-kb cutoff and sequenced on a single-molecule real-time (SMRT) cell using P6-C4 chemistry with 360-min movie-time chemistry. Additional whole-genome sequencing (WGS) was performed using an Illumina HiSeq sequencer. Genome assembly involved a *de novo* approach, using default HGAP 4 settings for the assembly of 96,269 PacBio reads (average length, 10,760 bp), before manual curation and validation. Iterative read mapping of Illumina sequences using custom settings in Geneious 10.1.3 ([@B6]) was used to identify assembly errors, primarily single-base insertions and deletions, and for variant correction (0.7 minimum variant frequency, 5× minimum coverage). Custom settings included allowed gaps (15% maximum/read and 15-bp maximum size); word and index word lengths of 18 and 13, respectively; and 20% maximum mismatch/read and maximum ambiguity of 4.

The K34-7 genome consists of a 7,038,012-bp chromosome and one plasmid, pK34-7-1 (4,440 bp). A P. aeruginosa genomic island 5 (PAGI-5)-like hybrid ([@B7]) pathogenicity island (84,893 bp) and bacteriophage (38,832 bp) were found on the chromosome (positions 4154015 to 4238618 and 6469185 to 6508016, respectively). The XDR K34-7 phenotype is predominantly due to genes associated with three chromosomally located class 1 integrons, including genes imparting resistance to aminoglycosides \[*aac(3)*, *aac(3)-I*, *aac(6´)-Il*, *aadA2*, and *aph(3´)-IIb*\], β-lactams (*bla*~OXA-4~, *bla*~OXA-486~, *bla*~PDC-3~, and *bla*~VIM-2~), chloramphenicol (*catB*, *cmlA6*, and *floR*), trimethoprim (*dfrB5*), fosfomycin (*fosA*), sulfonamide (*sul1*), and tetracycline (*tetG*), as annotated by the PGAP pipeline ([@B8]). Additionally, *tetK*, encoding the tetracycline efflux pump TetK, is found on the small pK34-7-1 plasmid.

A region (1936000 to 2043700) of 12 direct tandem repeats (7,122 bp, 11.5× mean Illumina coverage) encodes a zonular occludens toxin, previously characterized in Vibrio cholerae ([@B9], [@B10]). Similar regions appear in other P. aeruginosa genomes but not in the ST233 P. aeruginosa PA83 genome ([@B5]). Additionally, P. aeruginosa K34-7 contains a type I-F CRISPR-Cas system (1656563 to 1664702), previously described in P. aeruginosa strain UCBPP-PA14 ([@B11]).

Complete high-quality bacterial genomes facilitate further research into mechanisms of resistance and their dissemination and aid in the development of new therapies for XDR infections.
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This complete genome project has been deposited at GenBank under the accession numbers [CP029707](https://www.ncbi.nlm.nih.gov/nuccore/CP029707) and [CP029708](https://www.ncbi.nlm.nih.gov/nuccore/CP029708).
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